Ignite Creation Date:
2025-12-24 @ 10:45 PM
Ignite Modification Date:
2025-12-25 @ 8:16 PM
Study NCT ID:
NCT03534635
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-02-21
First Post:
2018-04-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-01
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-04-19
First Submit QC Date:
None
Study First Post Date:
2018-05-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-16
Last Update Post Date:
2023-02-21
Last Update Post Date Type:
ACTUAL